Generic Semaglutide Injection
Chronic Weight Management
Key Facts
Indication
Chronic Weight Management
Phase
ANDA Approved
Status
Launched (India)
Company
About Sun Pharmaceutical
Sun Pharma's mission is to provide high-quality, affordable medicines globally, improving access and patient care. Its key achievement is transforming from a small startup in 1983 into a global pharmaceutical titan with a market cap exceeding $45 billion, largely through strategic acquisitions like Ranbaxy. The company's strategy is built on a dual engine: dominating the complex generics market while accelerating growth in high-margin specialty products and novel drug delivery systems across key therapeutic areas like dermatology, ophthalmology, and oncology.
View full company profileTherapeutic Areas
Other Chronic Weight Management Drugs
| Drug | Company | Phase |
|---|---|---|
| CONTRAVE | Currax Pharmaceuticals | Approved |
| QSIVA®/QSYMIA® | VIVUS | Approved |